Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (359)
Reports (1)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1190)
Regions
Africa (62)
Americas (192)
Eastern Mediterranean (12)
Europe (160)
Global (1)
South-East Asia (11)
Western Pacific (39)
Diseases
COVID-19 (1589)
Chikungunya (13)
Cholera (35)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (13)
Moderate (9)
Low (130)
Critically low (729)
Not applicable (309)
1589 results found
2021
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Vaccination of people with a history of Covid-19
2021
∙
Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 - AstraZeneca vaccine
2021
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19 - Janssen COVID-19 vaccine
2021
∙
Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 - the Moderna Covid-19 mRNA (nucleoside modified) vaccine
2021
Vaccination strategy against COVID19 in Spain
2021
∙
SAGE
WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply - 16 July 2021
2020
∙
Singh, A.; Gupta, L.; Gupta, V.
Heterologous Protection to COVID-19 with BCG Vaccine: Deciphering the Reality Using Meta-Analysis Approach
2020
∙
Leeson, C. E. Ismail, A. Hashad, M. M. Elmansy, H. Shahrour, W. Prowse, O. Kotb, A.
Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
2020
∙
Del Riccio, M. Lorini, C. Bonaccorsi, G. Paget, J. Caini, S.
The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature
2020
∙
Checcucci, E. Piramide, F. Pecoraro, A. Amparore, D. Campi, R. Fiori, C. Elhage, O. Kotecha, P. Vyakarnam, A. Serni, S. Dasgupta, P. Porpiglia, F.
The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register